Found 59 matching trials
A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)
PHASE4Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
PHASE2The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Location
Multiple Locations
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
PHASE2This is a 52 week, single center, randomized, double-blind, placebo-control...
Location
Hospital for Special Surgery
Tocilizumab in Cardiac Transplantation
PHASE2The purpose of this research study is to see if a study drug called Tociliz...
Location
Cedars Sinai Medical Center (CACS)
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)
PHASE3This study was designed to assess the efficacy and safety of CellCept (1 g ...
Location
Multiple Locations
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
PHASE2The purpose of this study is to learn whether atacicept treatment leads to ...
Location
Tulane University Hospital and Clinic Department of Internal Medicine
Safety and Efficacy Study of Rituximab in Renal Transplantation
PHASE1Current strategies for the medical management of transplant patients are la...
Location
Transplantation Surgery, Karolinska University Hospital
Dupilumab Therapy in Nephrotic Syndrome in Children
PHASE2The goal of this clinical trial is to learn if dupilumab works to treat sev...
Location
National University Hospital
Mesenchymal Stromal Cells in Living Donor Kidney Transplantation
PHASE2Kidney transplantation is a good treatment option for people with kidney di...
Status
Active Not Recruiting
Location
Houston Methodist Hospital System
REduCing Immunogenicity to PegloticasE (RECIPE) Study
PHASE2Pegloticase treatment for chronic refractory gout is limited by immunogenic...
Location
University of Alabama at Birmingham